Judith Greciet
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Judith Greciet
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin.
34
| Non-Profit Organization | Miscellaneous Commercial Services | 34 |
| Public Company | Pharmaceuticals: Major | 31 | |
Onxeo US
1
| Subsidiary | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Judith Greciet
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| SENSORION | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Director/Board Member | |
| Aventis, Inc. | Corporate Officer/Principal Comptroller/Controller/Auditor Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | ||
| THERADIAG | Medical Specialties | Director/Board Member Chairman Chief Executive Officer | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Founder Director of Finance/CFO Chairman | |
| AB SCIENCE | Pharmaceuticals: Other | Director/Board Member Director/Board Member Founder | |
| EUROBIO SCIENTIFIC | Medical Specialties | Director/Board Member Chief Executive Officer Director/Board Member | |
| OSE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Founder Director/Board Member Corporate Officer/Principal | |
Horama SA
 Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Chief Executive Officer Chairman | |
| ADVICENNE | Pharmaceuticals: Generic | Director/Board Member Chairman Director/Board Member | |
| TXCELL | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Director/Board Member | |
Theravectys SAS
 Theravectys SAS BiotechnologyHealth Technology Theravectys SAS provides biotechnology research services. It is working on the development of a therapeutic vaccine against HIV. The company was founded on May 17, 2005 and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer Chairman Director/Board Member | |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ABLYNX | Biotechnology | Chairman Chairman | |
Institut Pasteur
 Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | Director/Board Member Corporate Officer/Principal | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| SANOFI | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
| École Normale Supérieure | College/University | Doctorate Degree Graduate Degree | |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | Corporate Officer/Principal Director of Finance/CFO | |
Tc Land Expression SA
 Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Miscellaneous Commercial Services | Director/Board Member Chief Operating Officer | |
| THERANEXUS | Pharmaceuticals: Major | Director/Board Member Founder | |
| ABIVAX | Pharmaceuticals: Other | Director/Board Member Corporate Officer/Principal | |
Auriga Partners SA
 Auriga Partners SA Investment ManagersFinance Auriga Partners SA (Auriga) is an independent, management-owned venture capital firm which was founded by Patrick Bamas, Jacques Chatain and Bernard Daugeras in 1998. Headquartered in Paris, the firm's core activity is enterprise creation. In addition to providing a network of contacts capable of accelerating internationalization, and furthering strategic partnerships and business deals, Auriga manages several seed and early-stage funds specializing in information technology and life sciences. | Investment Managers | Director/Board Member Director/Board Member | |
Hemarina SA
 Hemarina SA BiotechnologyHealth Technology Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France. | Biotechnology | Chairman Chief Executive Officer | |
HRA Pharma Development SARL
 HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology HRA Pharma Development SARL develops medicines and products for women's health and endocrinology. It offers emergency contraception, uterine fibroids, regular contraception, intimate health, genital herpes, and Lysosafe service. The company was founded by André Ulmann in 1996 and is headquartered in Châtillon, France. | Pharmaceuticals: Major | Director/Board Member Founder | |
| CARMAT | Medical Specialties | Director/Board Member Investor Relations Contact | |
Atlanpole Biotherapies
 Atlanpole Biotherapies Miscellaneous Commercial ServicesCommercial Services Atlanpole Biotherapies provides immunotherapy, regenerative medicine, and radio pharmacy bio cluster services. The company is based in Nantes, France. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| Healthtech For Care | Corporate Officer/Principal Chairman | ||
Olgram SAS
 Olgram SAS Miscellaneous Commercial ServicesCommercial Services Olgram SAS provides scientific research and development services. The company is based in Brehan, France. The French company was founded by Hervé Balusson, Maryvonne Hiance, Karim Asehnoune, Pi Nyvall Collén, Pierre Rocheteau. Pierre Rocheteau has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder Founder | |
| CIRCIO HOLDING ASA | Biotechnology | Director/Board Member Chairman | |
Pharmaleads SA
 Pharmaleads SA Pharmaceuticals: MajorHealth Technology Pharmaleads SA specializes in the detection, inhibition and modulation of proteases involved in human diseases. It designs and develops analgesic drugs with the aim to revolutionize the treatment of severe pain, with no side effects. The firm's products include high fluorescence substrates for proteases, substrates for BoNT quantification, and EzyBot, a field kit for botulinum toxin detection. The company was founded in 2000 by Bernard Roques and Marie-Claude Fournié-Zaluski and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Founder | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree Doctorate Degree | |
CYTOO SA
 CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member Director/Board Member | |
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| MITHRA PHARMACEUTICALS S.A. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| Ecole Polytechnique | College/University | Undergraduate Degree Undergraduate Degree | |
| CORETECH 5 | Agricultural Commodities/Milling | Director/Board Member Director/Board Member | |
Elaia Partners SAS
 Elaia Partners SAS Investment ManagersFinance Elaia Partners SAS (Elaia) is an independent French private equity boutique which was founded in 2002. Named after the Greek word for olive tree, the symbol of resilience, longevity and prosperity, Elaia focuses on software technology companies. The firm is headquartered in Paris and manages Elaia Ventures, a French FCPR fund backed by financial institutions, industrial investors and family offices. | Investment Managers | Private Equity Investor Private Equity Investor | |
Isocell SA
 Isocell SA Food RetailRetail Trade Isocell SA operates as a holding company with interests in the manufacture of food supplements. It develops proprietary formulation for super-oxyde dismutase. The firm also targets food areas including sodas, sport drinks and dairies with wellness claims. It also engages in the ownership and operations of medical laboratories. The company was founded by Francois Vix on July 9, 2001 and is headquartered in Paris, France. | Food Retail | Director/Board Member Director/Board Member | |
| STALLERGENES | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree |
Statistik
International
| Frankreich | 42 |
| Norwegen | 4 |
| Vereinigte Staaten | 3 |
| Belgien | 3 |
| Dänemark | 2 |
Sektoral
| Health Technology | 32 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Process Industries | 3 |
| Finance | 3 |
Operativ
| Director/Board Member | 346 |
| Chairman | 123 |
| Corporate Officer/Principal | 110 |
| Independent Dir/Board Member | 88 |
| Chief Executive Officer | 76 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Per Anders Göte Samuelsson | 36 |
| Bo Jesper Hansen | 34 |
| Russell Greig | 31 |
| Joseph Zakrzewski | 30 |
| Franck Lescure | 28 |
| Jean-Pierre Kinet | 26 |
| Michel Arié | 25 |
| Jean Bizzari | 24 |
| Catherine Dunand | 23 |
| Patrick J. Langlois | 23 |
| David Solomon | 22 |
| Franck Grimaud | 22 |
| Damian Marron | 21 |
| Graham Dixon | 18 |
| Elvira Sanz Urgoiti | 16 |
- Börse
- Insiders
- Judith Greciet
- Unternehmensverbindungen
